Inosine boosts infant antiviral immunity

Area of Science:

• Microbiology
• Immunology
• Metabolomics

Background:

• Early-life antibiotic exposure can negatively impact the gut microbiota composition.
• Disruption of the gut microbiota in newborns is linked to impaired immune system development, particularly antiviral responses.

Purpose of the Study:

• To investigate the protective effects of microbial metabolites against antibiotic-induced immunodeficiency in newborns.
• To identify specific metabolites that can restore antiviral immunity following early-life antibiotic exposure.

Main Methods:

• Utilized a mouse model to study the effects of early-life antibiotic exposure on gut microbiota and immune responses.
• Analyzed the impact of inosine, a gut bacterial metabolite, on T cell function and gene regulation.
• Assessed lung immune defenses against respiratory viral infections.

Main Results:

• Antibiotic exposure in early life led to significant alterations in the gut microbiota and compromised T cell-mediated antiviral immunity.
• Administration of inosine restored the function of antiviral T cells, even in the presence of antibiotic-induced microbiota disruption.
• Inosine modulated gene expression in immune cells, enhancing lung immune defenses and improving outcomes against respiratory viral infections.

Conclusions:

• Gut microbiota-derived metabolites, such as inosine, play a crucial role in shaping neonatal immune responses.
• Inosine represents a potential therapeutic strategy to counteract the detrimental effects of early antibiotic exposure on antiviral immunity.
• Restoring microbial metabolite levels may be key to bolstering infant immune defenses against common respiratory pathogens.